Indian Council of Medical Research (ICMR), in a study, said plasma therapy for COVID-19 neither reduces the death risk nor does it slow down the progression of the disease from mild to severe stage. In plasma therapy, antibodies from the…

A promising Oxford University and AstraZeneca coronavirus vaccine trial has been halted due to an adverse reaction in a trial participant. AstraZeneca said “As part of the ongoing randomized, controlled clinical trials of the AstraZeneca Oxford coronavirus vaccine, AZD1222, a…

Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot.